Paper28323486
Enterolactone Induces G1-phase Cell Cycle Arrest in Nonsmall Cell Lung Cancer Cells by Downregulating Cyclins and Cyclin-dependent Kinases.
Chikara S and 6 others. Nutr Cancer, 2017. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. Enterolactone Induces G1-phase Cell Cycle Arrest in Nonsmall Cell Lung Cancer Cells by Downregulating Cyclins and Cyclin-dependent Kinases. Papers, record 28323486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28323486
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| 4-Butyrolactone | Major topic |
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Cyclin-Dependent Kinases | Major topic |
| Cyclins | Major topic |
| Lignans | Major topic |
| Lung Neoplasms | Major topic |
| Antineoplastic Agents, Phytogenic | |
| Cell Line, Tumor | |
| Cell Proliferation | |
| Dose-Response Relationship, Drug | |
| Down-Regulation | |
| G1 Phase Cell Cycle Checkpoints | |
| Gene Expression Regulation, Neoplastic | |
| Humans |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| P30 GM103332 | NIGMS NIH HHS | United States | P30GM103332 | PubMed and NIH |
Source NIH RePORTER
References33
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33467817 | Flaxseed Lignans: Source, Biosynthesis, Metabolism, Antioxidant Activity, Bio-Active Components, and Health Benefits. | Compr Rev Food Sci Food Saf | 2010 | https://conductscience.org/library/papers/33467817 | PubMed |
| 2 | 12429338 | Effect of flaxseed supplementation on prostatic carcinoma in transgenic mice. | Urology | 2002 | https://conductscience.org/library/papers/12429338 | PubMed |
| 3 | 17909619 | New molecularly targeted therapies for lung cancer. | J Clin Invest | 2007 | https://conductscience.org/library/papers/17909619 | PubMed |
| 4 | 1584708 | The effect of flaxseed supplementation on the initiation and promotional stages of mammary tumorigenesis. | Nutr Cancer | 1992 | https://conductscience.org/library/papers/1584708 | PubMed |
| 5 | 23354422 | Consumption of flaxseed, a rich source of lignans, is associated with reduced breast cancer risk. | Cancer Causes Control | 2013 | https://conductscience.org/library/papers/23354422 | PubMed |
| 6 | 18083772 | Dietary flaxseed enhances antioxidant defenses and is protective in a mouse model of lung ischemia-reperfusion injury. | Am J Physiol Lung Cell Mol Physiol | 2008 | https://conductscience.org/library/papers/18083772 | PubMed |
| 7 | 26473769 | Inhibitory Effects of Enterolactone on Growth and Metastasis in Human Breast Cancer. | Nutr Cancer | 2015 | https://conductscience.org/library/papers/26473769 | PubMed |
| 8 | 8875553 | Antitumorigenic effect of a mammalian lignan precursor from flaxseed. | Nutr Cancer | 1996 | https://conductscience.org/library/papers/8875553 | PubMed |
| 9 | 1657368 | The effect of flaxseed supplementation on early risk markers for mammary carcinogenesis. | Cancer Lett | 1991 | https://conductscience.org/library/papers/1657368 | PubMed |
| 10 | 17876055 | Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway. | Mol Cancer Ther | 2007 | https://conductscience.org/library/papers/17876055 | PubMed |
| 11 | 15897583 | Dietary flaxseed alters tumor biological markers in postmenopausal breast cancer. | Clin Cancer Res | 2005 | https://conductscience.org/library/papers/15897583 | PubMed |
| 12 | 24429845 | Metabolism of secoisolariciresinol-diglycoside the dietary precursor to the intestinally derived lignan enterolactone in humans. | Food Funct | 2014 | https://conductscience.org/library/papers/24429845 | PubMed |
| 13 | 20721350 | Flaxseed ingestion alters ratio of enterolactone enantiomers in human serum. | J Nutr Metab | 2010 | https://conductscience.org/library/papers/20721350 | PubMed |
| 14 | 12968067 | Exposure to flaxseed or its purified lignan during suckling inhibits chemically induced rat mammary tumorigenesis. | Exp Biol Med (Maywood) | 2003 | https://conductscience.org/library/papers/12968067 | PubMed |
| 15 | 16936740 | RB and cell cycle progression. | Oncogene | 2006 | https://conductscience.org/library/papers/16936740 | PubMed |
| 16 | 8681458 | Flaxseed and its lignan and oil components reduce mammary tumor growth at a late stage of carcinogenesis. | Carcinogenesis | 1996 | https://conductscience.org/library/papers/8681458 | PubMed |
| 17 | 10765979 | Regulation of the G1 phase of the mammalian cell cycle. | Cell Res | 2000 | https://conductscience.org/library/papers/10765979 | PubMed |
| 18 | 16365068 | A lignan complex isolated from flaxseed does not affect plasma lipid concentrations or antioxidant capacity in healthy postmenopausal women. | J Nutr | 2006 | https://conductscience.org/library/papers/16365068 | PubMed |
| 19 | 23907590 | Flaxseed (Linum usitatissimum L.) and its total non-digestible fraction influence the expression of genes involved in azoxymethane-induced colon cancer in rats. | Plant Foods Hum Nutr | 2013 | https://conductscience.org/library/papers/23907590 | PubMed |
| 20 | 19064574 | Flaxseed supplementation (not dietary fat restriction) reduces prostate cancer proliferation rates in men presurgery. | Cancer Epidemiol Biomarkers Prev | 2008 | https://conductscience.org/library/papers/19064574 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40487092 | Nettle supplementation improves antioxidant status and modulates inflammatory response by altering lysophosphatidylcholines and enterolactone metabolism in dairy cows. | Anim Nutr | 2025 | https://conductscience.org/library/papers/40487092 | PubMed |
| 36104587 | Molecular mechanisms of bilirubin induced G1 cell cycle arrest and apoptosis in human breast cancer cell lines: involvement of the intrinsic pathway. | Mol Biol Rep | 2022 | https://conductscience.org/library/papers/36104587 | PubMed |
| 36077483 | Synthetic Secoisolariciresinol Diglucoside (LGM2605) Prevents Asbestos-Induced Inflammation and Genotoxic Cell Damage in Human Mesothelial Cells. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36077483 | PubMed |
| 35472101 | Secoisolariciresinol diglucoside induces pyroptosis by activating caspase-1 to cleave GSDMD in colorectal cancer cells. | Drug Dev Res | 2022 | https://conductscience.org/library/papers/35472101 | PubMed |
| 33243735 | [Expression of CDC25A in non-small cell lung cancer and its relationship with let-7 gene]. | Nan Fang Yi Ke Da Xue Xue Bao | 2020 | https://conductscience.org/library/papers/33243735 | PubMed |
| 32405336 | Quinacrine inhibits GSTA1 activity and induces apoptosis through G1/S arrest and generation of ROS in human non-small cell lung cancer cell lines. | Oncotarget | 2020 | https://conductscience.org/library/papers/32405336 | PubMed |
| 32184668 | Leucine Zipper-EF-Hand Containing Transmembrane Protein 1 Is a Potential Prognostic Biomarker and Promotes Cell Progression in Prostate Cancer. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/32184668 | PubMed |
| 31571912 | A novel CXCL8 analog is effective in inhibiting the growth via cell cycle arrest and attenuating invasion of Lewis lung carcinoma. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/31571912 | PubMed |
| 30771348 | Anticancer and antimetastatic potential of enterolactone: Clinical, preclinical and mechanistic perspectives. | Eur J Pharmacol | 2019 | https://conductscience.org/library/papers/30771348 | PubMed |
| 30684594 | RLIP inhibition suppresses breast-to-lung metastasis. | Cancer Lett | 2019 | https://conductscience.org/library/papers/30684594 | PubMed |
| 30621290 | LGM2605 Reduces Space Radiation-Induced NLRP3 Inflammasome Activation and Damage in In Vitro Lung Vascular Networks. | Int J Mol Sci | 2019 | https://conductscience.org/library/papers/30621290 | PubMed |
| 30056618 | Seed coats as an alternative molecular factory: thinking outside the box. | Plant Reprod | 2018 | https://conductscience.org/library/papers/30056618 | PubMed |
| 29736205 | MiR-200a inhibits cell proliferation and EMT by down-regulating the ASPH expression levels and affecting ERK and PI3K/Akt pathways in human hepatoma cells. | Am J Transl Res | 2018 | https://conductscience.org/library/papers/29736205 | PubMed |
| 29075366 | The Synthetic Lignan Secoisolariciresinol Diglucoside Prevents Asbestos-Induced NLRP3 Inflammasome Activation in Murine Macrophages. | Oxid Med Cell Longev | 2017 | https://conductscience.org/library/papers/29075366 | PubMed |
| 29074535 | Flaxseed Consumption Inhibits Chemically Induced Lung Tumorigenesis and Modulates Expression of Phase II Enzymes and Inflammatory Cytokines in A/J Mice. | Cancer Prev Res (Phila) | 2018 | https://conductscience.org/library/papers/29074535 | PubMed |
Genes24
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/28323486
GET https://conductscience.org/api/papers/v1/28323486/references?page=2